Metabolic disorders have become more severe due to dietary changes, lifestyle changes, and growing urbanization, which have increased demand for novel treatments like GLP-1 analogues
Finally, as safe and effective as these medications are, there is the chance of a serious complication like pancreatitis, gallbladder dysfunction, or even thyroid tumors
WADA published the outcomes of a review of Cannabinoids in 2022 discussing how marijuana and cannabinoids meet the WADA Prohibited List inclusion criteria
The liver at the nexus of host-microbial interactions
Oral formulations like Oral Semaglutide ($289/month) and Oral Tirzepatide ($349/month) offer convenience for needle-averse patients, though they require consistent daily dosing on an empty stomach for optimal absorption
47.3% of patients with and 36.3% without type 2 diabetes subsequently reinitiated a GLP-1 RA within 1 year